CCI vs CMPX · P/E 40, rev $6.57B vs $367.4M cap
Crown Castle (CCI) versus Compass Therapeutics Inc. (CMPX) — a side-by-side from cached financials, not a winner call.
Crown Castle (CCI) is a reit - specialty company listed on US.
Compass Therapeutics Inc. (CMPX) is a biotechnology company listed on US.
Latest reported CCI revenue for 2024-12-31 was $6.57B. Net income was -$3.90B. Revenue was down 5.9% from 2023-12-31 to 2024-12-31. CCI currently screens at market cap $40.93B and trailing P/E 39.6.
CMPX does not have a complete income-statement cache yet.
CCI currently screens at market cap $40.93B and trailing P/E 39.6. CMPX currently screens at market cap $367.4M.
Not investment advice. Open the CCI and CMPX stock pages for the full models.
Not investment advice.